Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Clinical management of localized colon cancer with capecitabine.

Quidde J, Arnold D, Stein A.

Clin Med Insights Oncol. 2012;6:363-73. doi: 10.4137/CMO.S8194. Epub 2012 Nov 5.

2.

The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P.

Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv, 1-185. Review.

3.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
4.

Adjuvant therapy for early colon cancer: current status.

Stein A, Hiemer S, Schmoll HJ.

Drugs. 2011 Dec 3;71(17):2257-75. doi: 10.2165/11594490-000000000-00000. Review.

PMID:
22085384
5.
6.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
7.
8.

Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence.

Comella P, Casaretti R, Sandomenico C, Avallone A, Franco L.

Drugs. 2008;68(7):949-61. Review.

PMID:
18457461
9.

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

Van Cutsem E, Verslype C, Tejpar S.

Semin Oncol. 2005 Feb;32(1):43-51. Review.

PMID:
15726505
10.

The role of capecitabine in locally advanced rectal cancer treatment: an update.

Fernández-Martos C, Nogué M, Cejas P, Moreno-García V, Machancoses AH, Feliu J.

Drugs. 2012 May 28;72(8):1057-73. doi: 10.2165/11633870-000000000-00000. Review.

PMID:
22621694
11.
12.
13.

The role of capecitabine in the treatment of colorectal cancer in the elderly.

Pasetto LM, Monfardini S.

Anticancer Res. 2006 May-Jun;26(3B):2381-6. Review.

14.

Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.

Corvò R, Pastrone I, Scolaro T, Marcenaro M, Berretta L, Chiara S.

Tumori. 2003 Jul-Aug;89(4):361-7. Review.

PMID:
14606636
15.

Evolution of capecitabine dosing in colorectal cancer.

Sun W.

Clin Colorectal Cancer. 2010 Jan;9(1):31-9. doi: 10.3816/CCC.2010.n.004. Review.

PMID:
20100686
16.

Capecitabine (Xeloda): from the laboratory to the patient's home.

Pentheroudakis G, Twelves C.

Clin Colorectal Cancer. 2002 May;2(1):16-23. Review.

PMID:
12453332
17.

The rational development of capecitabine from the laboratory to the clinic.

Pentheroudakis G, Twelves C.

Anticancer Res. 2002 Nov-Dec;22(6B):3589-96. Review.

PMID:
12552961
18.

Adjuvant chemotherapy for stages II, III and IV of colon cancer.

Grávalos C, García-Escobar I, García-Alfonso P, Cassinello J, Malón D, Carrato A.

Clin Transl Oncol. 2009 Aug;11(8):526-33. Review.

PMID:
19661027
20.

[Adjuvant therapy in colon cancer].

Reinacher-Schick A, Arnold D, Trarbach T, Ridwelski K, Bruch HP, Kirchner T, Kubicka S, Schmoll HJ.

Onkologie. 2010;33 Suppl 4:2-7. doi: 10.1159/000308436. Epub 2010 Apr 23. Review. German.

PMID:
20431306

Supplemental Content

Support Center